Gene editing using CRISPR and CAS technologies has demonstrated significant potential in treating rare genetic diseases. These groundbreaking techniques offer hope to patients and families affected by these conditions, as traditional treatment options are often limited or non-existent. This article explores the use of CRISPR and CAS gene-editing technologies in addressing rare diseases, their challenges, and the future prospects of gene therapy in this context.
CRISPR and CAS gene are genomes editing technology that uses enzymes to cut and paste DNA. This technology has allowed researchers to edit parts of the genome by removing, adding or altering sections of the genetic code. Some key advantages of CRISPR technology are its simplicity, high efficiency, low cost and ease of use. The products associated with this market are gene editing kits, cell lines, enzymes and vectors. These products find applications in genetic engineering, cancer therapies ... Read more
